Published: Wed, May 16, 2018

Nevada Attorney General Adam Laxalt sues maker of OxyContin

Nevada Attorney General Adam Laxalt sues maker of OxyContin

This story was updated May 15, 2018, at 10:19 p.m. with more information.

The lawsuit, filed by the attorney general's Bureau of Consumer Protection, said the company, well known for its production of brand-name oxycodone prescription OxyContin, understated the risks associated with opioid use while it allegedly exaggerated the benefits, a news release from Laxalt's office said.

"My office is holding Purdue Pharma accountable for fueling the nation's opioid epidemic by deceptive marketing of its prescription opioid painkillers, including OxyContin.", Paxton said.

The suit alleges Purdue "misrepresented and trivialized the risk of addiction from "prolonged use" and "re-assured prescribers" that signs of addiction were due to so-called "pseudo-addiction" among other reasons".

"My office is holding Purdue Pharma accountable for fueling the nation's opioid epidemic by deceptively marketing prescription painkillers including OxyContin when it knew their drugs were potentially unsafe and that its use had a high likelihood of leading to addiction", Attorney General Paxton said.


FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt.

State Attorney General Herbert Slatery announced the suit, filed in Knox County, on Tuesday. The lawsuit also accuses Purdue Pharma of targeting seniors and other "vulnerable" populations. Company spokesman Bob Josephson said the civil lawsuits followed months of negotiations with state officials to address the opioid crisis.

In a statement, Connecticut-based Purdue Pharma denied the claims and said the company will defend itself.

Separate litigation involving at least 433 lawsuits by US cities and counties has been consolidated in a federal court in Cleveland, Ohio. As the national death toll from opioid addiction rises, Texas is now suing a national drug manufacturer for aiding in the epidemic.

Like this: